Xenon Pharmaceuticals Inc. (XENE)
NASDAQ·Healthcare·Biotechnology
$54.53
+0.50%
Mkt Cap $4.36B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | -$178.57K | — | — | -$1.20 | -$1.31 | -9.17% | — | — |
| Q4 2025 Nov 3, 2025 | — | — | — | -$1.16 | -$1.15 | +0.86% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$1.03 | -$1.07 | -3.88% | — | — |
| Q2 2025 May 12, 2025 | $1.91M | $7.50M | +293.44% | -$0.94 | -$0.83 | +11.70% | — | — |
| Q1 2025 Feb 27, 2025 | $312.50K | — | — | -$0.89 | -$0.84 | +5.62% | — | — |
| Q4 2024 Nov 12, 2024 | $294.12K | — | — | -$0.82 | -$0.81 | +0.69% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.72 | -$0.75 | -4.17% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.69 | -$0.62 | +10.14% | — | — |
| Q1 2024 Feb 29, 2024 | $1.89M | $5.38M | +184.66% | -$0.76 | -$0.64 | +15.79% | — | — |
| Q4 2023 Nov 8, 2023 | $2.29M | — | — | -$0.75 | -$0.73 | +2.67% | — | — |
| Q3 2023 Aug 9, 2023 | $400.00K | — | — | -$0.69 | -$0.72 | -4.35% | — | — |
| Q2 2023 May 9, 2023 | $570.00K | — | — | -$0.62 | -$0.63 | -1.61% | — | — |
| Q1 2023 Mar 1, 2023 | $2.91M | $8.77K | -99.70% | -$0.58 | -$0.57 | +1.72% | — | — |
| Q4 2022 Nov 8, 2022 | $4.15M | $132.00K | -96.82% | -$0.52 | -$0.57 | -9.62% | — | — |
| Q3 2022 Aug 9, 2022 | $4.18M | $536.00K | -87.17% | -$0.49 | -$0.55 | -12.24% | — | — |
| Q2 2022 May 10, 2022 | $7.74M | $8.77M | +13.29% | -$0.38 | -$0.35 | +7.89% | — | — |
| Q1 2022 Mar 1, 2022 | $5.69M | $3.74M | -34.27% | -$0.47 | -$0.57 | -21.28% | — | — |
| Q4 2021 Nov 10, 2021 | $9.60M | $8.12M | -15.38% | -$0.44 | -$0.36 | +18.18% | — | — |
| Q3 2021 Aug 11, 2021 | $2.22M | $2.22M | +0.00% | -$0.49 | -$0.51 | -4.08% | — | — |
| Q2 2021 May 11, 2021 | $4.46M | $4.36M | -2.27% | -$0.45 | -$0.42 | +6.67% | — | — |